[ Price : $8.95]
A new JAMA research letter finds that more than 380 clinical trials supported by the NIH lost funding this year affecting about 1...[ Price : $8.95]
HHS secretary Robert F. Kennedy Jr. reviews options to scale back the operational role of FDA commissioner Marty Makary, including...[ Price : $8.95]
Zymeworks reports that its HER2-targeted bispecific antibody Ziihera (zanidatamab-hrii) significantly improved outcomes for patien...[ Price : $8.95]
Bristol Myers Squibb (BMS) and Johnson & Johnson stop their Phase 3 Librexia ACS trial of the investigational anticoagulant milvex...[ Price : $8.95]
FDA commissioner Marty Makary and CBER director Vinay Prasad preview upcoming agency reforms during an FDA Direct podcast focused ...[ Price : $8.95]
An Axios report examines growing criticism of recent FDA actions that are fueling uncertainty among drug developers and weakening ...[ Price : $8.95]
The ACLU files a lawsuit seeking to force FDA to release documents related to its ongoing safety review of mifepristone.[ Price : $8.95]
FDA says it is approving new labeling submitted by Sarepta Therapeutics for its gene therapy Elevidys (delandistrogene moxeparvove...